Opium is addictive because its active compounds closely mimic the brain’s own pain-relief and pleasure chemicals, hijacking the reward system in ways that reshape brain function with repeated use. The primary culprit is morphine, one of several alkaloids naturally present in the opium poppy, which binds to the same receptors your body’s endorphins use. What starts as a powerful wave of relief and euphoria quickly becomes something the brain depends on, as it dials down its own natural chemistry in response.
What’s in Opium That Hooks the Brain
Raw opium contains dozens of alkaloids, but three do the heavy lifting: morphine, codeine, and thebaine. Morphine is the most pharmacologically potent of the group and the main driver of addiction. It locks onto a specific type of receptor in the brain and spinal cord called the mu-opioid receptor, a protein embedded in nerve cell membranes that normally responds to your body’s own painkillers (endorphins and enkephalins).
When morphine binds to this receptor, it triggers the same signaling cascade those natural chemicals would, only far more intensely and for much longer. The receptor changes shape, activates proteins inside the cell, and sets off a chain reaction that suppresses pain signals and produces a deep sense of calm and well-being. Codeine, the second major alkaloid, is weaker on its own but gets partially converted into morphine by the liver, adding to the overall effect.
How Opium Rewires the Reward System
The brain has a built-in circuit for evaluating rewards, centered on a pathway that runs from a cluster of cells deep in the midbrain to a region called the nucleus accumbens. This pathway uses dopamine as its chemical messenger. Natural rewards like food, social connection, and sex cause modest bumps in dopamine along this route. Opiates cause a surge.
Morphine doesn’t raise dopamine directly. Instead, it silences a set of inhibitory cells that normally keep dopamine neurons in check. Think of it as releasing the brakes rather than pressing the accelerator. The result is a flood of dopamine in the nucleus accumbens, which the brain interprets as a signal that something extremely important just happened.
Critically, this dopamine surge doesn’t just produce pleasure. Research from Harvard Review of Psychiatry distinguishes between two components of reward: “liking” (the actual feeling of pleasure) and “wanting” (the motivational drive to seek the reward again). The dopamine pathway primarily drives wanting. This is why people in the grip of opioid addiction often describe compulsive cravings even when the drug has stopped feeling good. The brain has flagged opium as a top survival priority, and the wanting persists long after the liking fades.
Tolerance: Why the Same Dose Stops Working
With repeated opium use, nerve cells fight back against the constant stimulation. One of the key changes happens inside the cell at the molecular level. Normally, activating the mu-opioid receptor suppresses a signaling molecule called cAMP, which lowers cell activity and contributes to the calming, pain-relieving effect. After chronic exposure to morphine, cells ramp up production of the enzymes that make cAMP, essentially compensating for the drug’s presence. The system recalibrates to function “normally” only when the drug is on board.
This means the original dose no longer produces the same effect. Users need more opium to achieve the same level of pain relief or euphoria, a process called tolerance. At the same time, the brain reduces the number of mu-opioid receptors available on nerve cell surfaces, making each dose even less effective. These two changes together create a relentless upward pressure on consumption.
Your Brain’s Natural Painkillers Shut Down
One of the most consequential effects of regular opium use is what happens to the body’s own opioid system. Even short-term use of an external opiate suppresses the production of endorphins, your natural pain-relieving and mood-regulating chemicals. Chronic use goes further: it reduces both endorphin production and the number of receptors those endorphins would normally act on.
Studies in animals given chronic morphine show a clear decrease in the gene activity responsible for making beta-endorphin, the most important endorphin for pain and mood regulation. The practical consequence is stark. Without the drug, the user’s baseline state shifts to one of heightened pain sensitivity, low mood, and anxiety, because the natural system that would normally buffer those experiences has been suppressed. This creates a powerful negative reinforcement loop: using opium is no longer just about feeling good, it becomes about avoiding feeling terrible.
What Withdrawal Feels Like and Why
When someone dependent on opium stops using it, all those cellular adaptations that built up during tolerance are suddenly unopposed. The overactive cAMP system, no longer held in check by the drug, fires at full force. The result is a constellation of intensely uncomfortable symptoms: muscle aches, nausea and vomiting, diarrhea, sweating, rapid heartbeat, dilated pupils, severe insomnia, and goosebumps (the origin of the phrase “quitting cold turkey”).
Withdrawal typically begins within 8 to 24 hours of the last dose for shorter-acting opioids and peaks around 36 to 72 hours. The acute physical symptoms generally last about a week, though insomnia, anxiety, and cravings can linger for weeks or months. The severity of withdrawal powerfully reinforces continued use. Even a single re-exposure to the drug can restart compulsive use, because dopamine plays a critical role in this “priming” effect, where one dose reignites the wanting pathway.
Changes in the Decision-Making Brain
Opium doesn’t just affect reward and pain circuits. It also alters the prefrontal cortex, the part of the brain responsible for planning, impulse control, and weighing long-term consequences. A dense network of opioid receptors spans this region, and chronic opiate use induces both immediate and lasting changes in how these cells communicate.
The prefrontal cortex normally acts as a brake on impulsive behavior, helping you weigh the cost of a choice against its benefit. When this region is disrupted by chronic opioid exposure, the ability to override cravings weakens. This is one reason addiction is so difficult to manage through willpower alone. The very brain system you would rely on to say “no” has been compromised by the drug.
Why Some People Are More Vulnerable
Not everyone who uses opium becomes addicted, and genetics are part of the reason. The gene that codes for the mu-opioid receptor, called OPRM1, has a well-studied variation known as A118G. This single change swaps one amino acid for another in the receptor protein, likely affecting how many receptors are present on nerve cells and how effectively they transmit signals. Some research suggests that people carrying this variant need higher doses of opioids for pain relief and may face a higher risk of addiction, though findings have been inconsistent across studies.
The A118G variant is more common in people of Asian or European ancestry than in those of African or African American descent. Other variations in the same gene have been linked to addiction risk in specific populations, including Han Chinese, European Americans, and African Americans. Genetics is only one piece of the puzzle, though. Environmental factors like early trauma, chronic pain, mental health conditions, and access to opioids all interact with genetic vulnerability to determine who develops a substance use disorder.
How Addiction Is Recognized Clinically
Opioid use disorder is diagnosed when a pattern of use leads to significant problems or distress, with at least two of eleven criteria present within a twelve-month period. These include taking more than intended, unsuccessful attempts to cut down, spending excessive time obtaining or recovering from the drug, intense cravings, neglecting responsibilities, continued use despite relationship problems or physical harm, giving up activities, using in dangerous situations like driving, developing tolerance, and experiencing withdrawal.
The number of criteria met determines severity: two to three is considered mild, four to five moderate, and six or more severe. This framework reflects the current understanding that addiction exists on a spectrum rather than being an all-or-nothing condition. Someone can meet criteria for a mild disorder long before they experience the dramatic withdrawal and compulsive use associated with severe addiction, which is why early patterns of escalating use are worth paying attention to.